Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials
- 10 July 2008
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 17 (6) , 831-843
Abstract
Aim The aims of our study were to assess quality of life (QoL) as a prognostic factor of overall survival (OS) and to determine whether QoL data improved three prognostic classifications among French patients with advanced hepatocellular carcinoma (HCC). Results Among 538 included patients, QoL at baseline was available for 489 patients (90%). Longer median OS was significantly associated with higher Spitzer scores at baseline, ranging from 2.17 months (Spitzer = 3) to 8.93 months (Spitzer = 10). Variables retained in the multivariate Cox model were: jaundice, hepatomegaly, hepatalgia, portal thrombosis, alphafetoprotein, bilirubin, albumin, small HCC, and Spitzer QoL Index (hazard ratio = 0.84 95% CI [0.79–0.90]). According to Harrell’s C-index, QoL was the best prognostic variable to add. CLIP plus the Spitzer QoL Index had the most discriminating value (C = 0.71). Conclusions Our results suggest that QoL is an independent prognostic factor for survival in HCC patients with mainly alcoholic cirrhosis. The prognostic value of CLIP score could be improved by adding Spitzer QOL Index scores.Keywords
This publication has 61 references indexed in Scilit:
- Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)European Journal of Cancer, 2008
- Standardizing Patient-Reported Outcomes Assessment in Cancer Clinical Trials: A Patient-Reported Outcomes Measurement Information System InitiativeJournal of Clinical Oncology, 2007
- Prospective validation of the Barcelona Clinic Liver Cancer staging systemJournal of Hepatology, 2006
- Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient DataJournal of Clinical Oncology, 2004
- Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancerEuropean Journal of Cancer, 2004
- A new prognostic classification for predicting survival in patients with hepatocellular carcinomaJournal of Hepatology, 1999
- Health‐related quality of life assessed before and during chemotherapy predicts for survival in multiple myelomaBritish Journal of Haematology, 1997
- Critical review of the international assessments of health-related quality of lifeQuality of Life Research, 1993
- Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanomaEuropean Journal of Cancer, 1993
- Measuring the quality of life of cancer patientsJournal of Chronic Diseases, 1981